Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hydroxyurea

J Timson

    Mutation Research
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Hydroxyurea (HU) is an anti-cancer drug that inhibits DNA synthesis and cell division. While effective, it can cause chromosome damage and is teratogenic, with its core chemical structure responsible for its activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of orotic acid on the mitosis of phytohaemagglutinin stimulated human lymphocytes in culture.

    Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen·2017
    Same author

    Effect of urethane (ethyl carbamate) on the mitosis of phytohaemagglutinin stimulated human lymphocytesin vitro.

    Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen·2017
    Same author

    Effect of testosterone on the division of phytohaemagglutinin stimulated human lymphocytesin vitro.

    Wilhelm Roux' Archiv fur Entwicklungsmechanik der Organismen·2017
    Same author

    Should ICSI be the treatment of choice for all cases of in-vitro conception?

    Human reproduction (Oxford, England)·2000
    Same author

    Intracytoplasmic sperm injection (ICSI) versus high insemination concentration (HIC) for human conception in vitro.

    Reproduction, fertility, and development·1995
    Same author

    Micro-assisted fertilization in patients who have failed subzonal insemination.

    Human reproduction (Oxford, England)·1994
    Same journal

    Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

    Mutation research·2026
    Same journal

    Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

    Mutation research·2026
    Same journal

    IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

    Mutation research·2026
    Same journal

    Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

    Mutation research·2026
    Same journal

    The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

    Mutation research·2026
    Same journal

    E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

    Mutation research·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Molecular Biology
    • Genetics

    Background:

    • Hydroxyurea (HU) is an established anti-leukemia and anti-tumor agent.
    • It exhibits inhibitory effects on DNA synthesis, RNA, and protein synthesis in various organisms.
    • HU also functions as an anti-mitotic and cytotoxic agent, with effects varying by concentration and exposure duration.

    Purpose of the Study:

    • To review the multifaceted biological activities of Hydroxyurea (HU).
    • To elucidate the mechanisms underlying HU's therapeutic and toxicological effects.
    • To identify the key chemical moiety responsible for HU's biological actions.

    Main Methods:

    • Literature review of studies on Hydroxyurea's effects.
    • Analysis of its impact on DNA synthesis, cell cycle, and DNA repair.

    Related Experiment Videos

  • Examination of its teratogenic and mutagenic potential.
  • Comparative studies to identify the active chemical group.

    • Main Results:

    • HU potently inhibits DNA synthesis, primarily during the S-phase of the cell cycle.
    • Evidence regarding HU's inhibition of DNA repair mechanisms is conflicting.
    • HU has been shown to induce chromosome damage and is teratogenic in mammals.
    • The =C--NHOH moiety is identified as the primary determinant of HU's biological activity.

    Conclusions:

    • Hydroxyurea is a potent inhibitor of DNA synthesis with anti-cancer applications.
    • Its anti-mitotic and cytotoxic properties are concentration-dependent.
    • HU poses risks including teratogenicity and chromosome damage, necessitating careful clinical use.
    • The specific chemical structure of HU is crucial for its observed biological effects.